Pacira BioSciences, Inc.

• A new era in pain care: Viatris to absorb Pacira in $1.65bn transaction
  BioXconomy · 12 Oct 2026
• Viatris to acquire Pacira BioSciences for $1.65 billion bolstering non-opioid pain treatment portfolio
  Indian Pharma Post · 11 Oct 2026
• Viatris to Acquire Pacira Biosciences for USD 1.65 Billion, Adds Exparel, Zilretta to Pain Portfolio
  Medical Dialogues · 10 Oct 2026
• Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies
  Viatris Newsroom · 08 Oct 2026
• Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal
  Reuters · 08 Oct 2026
• Viatris to snap up Pacira's non-opioid pain pipeline for $1.65B
  Fierce Pharma · 08 Oct 2026
• Viatris to Buy Pacira BioSciences for $1.65 Billion
  WSJ · 08 Oct 2026
• Viatris Acquires Pacira BioSciences for $1.65 Billion
  Pharmaceutical Executive · 08 Oct 2026
• Viatris to buy Pacira BioSciences in $1.65B deal
  TradingView · 08 Oct 2026
• Pacira BioSciences Stock Surges 44% on $1.7 Billion Viatris Acquisition
  Barron's · 08 Oct 2026
• Form 144 Pacira BioSciences For: 8 October By Investing.com
  Investing.com India · 08 Oct 2026
• Viatris to Acquire Pacira BioSciences in $1.65 Billion Deal
  NAVLIN DAILY · 08 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →